Insured patients may pay $50$300 in copays depending on formulary tier
Legal Implications As the class action gains traction, legal experts anticipate a thorough examination of the evidence surrounding the alleged failure of manufacturers to disclose adverse gastric effects
How TrimBody M.D
We only needed approval from the institutional review board' (Nair)
Kristensen SL, Rrth R, Jhund PS, Docherty KF, Sattar N, Preiss D, Kber L, Petrie MC, McMurray JJV (2019) Cardiovascular, mortality, kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
The key is to diagnose them early to prevent long-term complications